In continuing coverage on the radioactive pollution of residences around Coldwater Creek, Russia Today joined local media in covering the story of dangerous radioactive pollution resulting from the 1940’s Manhattan Project. Russia Today spoke to Faisal Khan, Director of Communicable Disease Control at St. Louis County Public Health Department. Dr. Khan told Russia Today that the issue of the radioactive pollution has been known for decades. Furthermore, Dr. Khan notes,
What we are seeing now is an environmental health disaster, slowly unfolding as a result of poor management many decades ago.
Product liability cases are generally pretty straight forward – a company manufactures/distributes a product that has caused injury. If that company didn’t make full disclosure of the risks to the patients and/or healthcare workers and people are harmed from those risks, then it is just to hold them accountable. Generally, doctors are not part of the product liability cases.
But, this article highlights the fault in generalizing product liability cases like that.
Since early 2014, it has been public knowledge (at least in medical communities) that using a power morcellator during a hysterectomy shreds tissue into tiny particles so that it can be easily sucked through a tiny opening during a minimally invasive operation. If the morcellator is being used on fibroids that are cancerous, then the cancerous mass will be broken into tiny particles that are quickly spread through the abdomen and this procedure has been linked to a very rare and aggressive cancer called leiomyosarcoma.
Despite the fact that a Boston anesthesiologist and her husband became vocal activists in December 2013 (upon her diagnosis with the same cancer), the FDA issued a safety communication to health professionals in April 2014, and public hearings were held in July 2014, there are still doctors that were performing hysterectomies using power morcellator in October 2014 and later. Those doctors should not be immune from being held accountable for the risks they took with their patients.
This article is the story of one woman who is currently fighting for her life in a New York hospital as a result of a hysterectomy in which her doctors used a power morcellator.
Unless you buried your head in the sand for the last 24 hours, it is not likely you missed the hype over the new “Female Viagra.” But, the marketing for the first ever female libido drug did not begin yesterday with FDA approval of Addyi. Sprout Pharmaceuticals, the company sure to reap the financial benefits of “pink is the new blue” is at least partially behind a well run marketing campaign that many are saying manipulates feminism by claiming Addyi will “Even the Score” of sexual health with men. Only time will tell whether the benefits will outweigh the risks, but it is imperative that women don’t just fall for the hype without understanding the risks involved.